• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROGENIKA BIOPHARMA, S.A ID CORE XT; ANTIGEN GENOTYPING TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROGENIKA BIOPHARMA, S.A ID CORE XT; ANTIGEN GENOTYPING TEST Back to Search Results
Catalog Number 1021920000
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/12/2024
Event Type  malfunction  
Event Description
It was reported that the sample (b)(6), from secretaria da saude do estado do ce, was tested with serology.The test result was negative (jka-), which contrasted with the molecular typing performed on (b)(6) 2024, using the id core xt assay which provided positive results (jka+), with id core xt analysis software v3.0.2.
 
Manufacturer Narrative
The genomic dna sample was sent to grifols laboratory solution for dna sequencing ofjk proximal promotor and exons 1-10.The genotype jk*01n.18(588g), jk*02w.03 was identified with a predicted phenotype jka-, jkb+weak.The reported serology is jka-, in agreement with sequencing and discrepant with id core xt which reported jka+.The variant c.190c>t is described by isbt as the null allele jk*01n.18 which is associated with jka negative expression.Id core xt reported a predicted jka+ phenotype, but jk*01n.18(588g) null allele is associated with a predicted jka- phenotype.This false positive result obtained by id core xt is considered a discrepant result, and then a malfunction this case report is associated with limitations of id core xt assay, as described in the id core xt package insert (sec 1 and 10 assay limitations).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ID CORE XT
Type of Device
ANTIGEN GENOTYPING TEST
Manufacturer (Section D)
PROGENIKA BIOPHARMA, S.A
ibaizabal bidea, edificio 504
parque tecnologico de bizkaia
derio, bizkaia 48160
SP  48160
Manufacturer Contact
jokin amo
ibaizabal bidea, edificio 504
parque tecnologico de bizkaia
derio, bizkaia 48160
SP   48160
MDR Report Key18694281
MDR Text Key336426868
Report Number3006413195-2024-00003
Device Sequence Number1
Product Code PEP
Combination Product (y/n)N
Reporter Country CodeBR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other Health Care Professional
Report Date 02/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1021920000
Device Lot Number0203000032
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/15/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/27/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-